United States Food and Drug Administration ('USFDA') conducted a cGMP inspection at our API manufacturing facility in Bommasandra, Bangalore from 20th January, 2020 to 24th January, 2020.
The inspection ended with 4 observations which were procedural in nature and none of which were repeat or related to data integrity. The Company is committed to address these observations and will submit its response to the USFDA within the stipulated time.
Shares of CIPLA LTD. was last trading in BSE at Rs.458.1 as compared to the previous close of Rs. 464.8. The total number of shares traded during the day was 98610 in over 2648 trades.
The stock hit an intraday high of Rs. 467.8 and intraday low of 456.6. The net turnover during the day was Rs. 45573292.